etomoxir has been researched along with 4-trimethylammonio-3-((tetradecylcarbamoyl)amino)butyrate in 1 studies
| Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (4-trimethylammonio-3-((tetradecylcarbamoyl)amino)butyrate) | Trials (4-trimethylammonio-3-((tetradecylcarbamoyl)amino)butyrate) | Recent Studies (post-2010) (4-trimethylammonio-3-((tetradecylcarbamoyl)amino)butyrate) |
|---|---|---|---|---|---|
| 260 | 8 | 93 | 8 | 0 | 5 |
| Protein | Taxonomy | etomoxir (IC50) | 4-trimethylammonio-3-((tetradecylcarbamoyl)amino)butyrate (IC50) |
|---|---|---|---|
| Carnitine O-palmitoyltransferase 2, mitochondrial | Rattus norvegicus (Norway rat) | 0.38 | |
| Carnitine O-palmitoyltransferase 2, mitochondrial | Homo sapiens (human) | 0.16 | |
| Carnitine O-palmitoyltransferase 1, liver isoform | Homo sapiens (human) | 1.05 | |
| Carnitine O-palmitoyltransferase 1, muscle isoform | Rattus norvegicus (Norway rat) | 0.915 | |
| Carnitine O-palmitoyltransferase 1, muscle isoform | Homo sapiens (human) | 3.425 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arduini, A; Ceccarelli, SM; Chomienne, O; Gubler, M | 1 |
1 other study(ies) available for etomoxir and 4-trimethylammonio-3-((tetradecylcarbamoyl)amino)butyrate
| Article | Year |
|---|---|
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Catalytic Domain; Diabetes Mellitus, Type 2; Energy Metabolism; Enzyme Activators; Ethylene Oxide; Heart Failure; Humans; Insulin Resistance; Isoenzymes; Lipid Metabolism; Myocardial Ischemia; Organ Specificity; Protein Conformation; Sequence Homology, Amino Acid; Stereoisomerism | 2011 |